Notes
proportion of glycosylated haemoglobin
2014 Canadian dollars
Reference
Skovgaard R, et al. Evaluating the Cost of Bringing People with Type 2 Diabetes Mellitus to Multiple Targets of Treatment in Canada. Clinical Therapeutics : 14 Jul 2015. Available from: URL: http://doi.org/10.1016/j.clinthera.2015.05.496
Rights and permissions
About this article
Cite this article
Liraglutide has lowest cost of T2DM control values in Canada. PharmacoEcon Outcomes News 733, 21 (2015). https://doi.org/10.1007/s40274-015-2322-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2322-4